"Streptococcus agalactiae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A bacterium which causes mastitis in cattle and occasionally in man.
| Descriptor ID |
D013292
|
| MeSH Number(s) |
B03.353.750.737.872.100 B03.510.400.800.872.100 B03.510.550.737.872.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Streptococcus agalactiae".
Below are MeSH descriptors whose meaning is more specific than "Streptococcus agalactiae".
This graph shows the total number of publications written about "Streptococcus agalactiae" by people in this website by year, and whether "Streptococcus agalactiae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 1 | 2 |
| 2014 | 2 | 1 | 3 |
| 2015 | 9 | 0 | 9 |
| 2016 | 7 | 2 | 9 |
| 2017 | 12 | 3 | 15 |
| 2018 | 2 | 1 | 3 |
| 2019 | 3 | 2 | 5 |
| 2020 | 2 | 2 | 4 |
| 2021 | 0 | 5 | 5 |
| 2022 | 1 | 4 | 5 |
| 2023 | 1 | 2 | 3 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Streptococcus agalactiae" by people in Profiles.
-
Distributions of candidate vaccine Targets, virulence Factors, and resistance features of invasive group B Streptococcus using Whole-Genome Sequencing: A Multicenter, population-based surveillance study. Vaccine. 2024 Jun 11; 42(16):3564-3571.
-
Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2330138.
-
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. N Engl J Med. 2023 Jul 20; 389(3):215-227.
-
Early-onset group B streptococcal disease in African countries and maternal vaccination strategies. Front Public Health. 2023; 11:1214844.
-
Association of infant Rib and Alp1 surface protein N-terminal domain immunoglobulin G and invasive Group B Streptococcal disease in young infants. Vaccine. 2023 03 03; 41(10):1679-1683.
-
Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021. Vaccine. 2022 07 30; 40(32):4283-4291.
-
Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob Health. 2022 Jun; 10(6):e807-e819.
-
Estimation of invasive Group B Streptococcus disease risk in young infants from case-control serological studies. BMC Med Res Methodol. 2022 03 27; 22(1):85.
-
South African Children: A Matched Cohort Study of Neurodevelopmental Impairment in Survivors of Invasive Group B Streptococcus Disease Aged 5 to 8 Years. Clin Infect Dis. 2022 01 20; 74(Suppl_1):S5-S13.
-
The antimicrobial activity of zinc against group B Streptococcus is strain-dependent across diverse sequence types, capsular serotypes, and invasive versus colonizing isolates. BMC Microbiol. 2022 01 13; 22(1):23.